跳至主要内容
临床试验/NCT05686928
NCT05686928已完成4 期

A Multi-center, Prospective Pilot Study on Safety and Effectiveness of a Healing Ointment as a Post-surgical Care

Galderma R&D2 个研究点 分布在 1 个国家目标入组 15 人开始时间: 2022年8月17日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
Galderma R&D
入组人数
15
试验地点
2
主要终点
Objective Erythema Assessment Using Clinical Grading Analog Scale

研究概览

简要总结

To evaluate benefits of a Healing Ointment in skin improvement after dermatologic procedures

详细描述

This is an open-label, multi-center study to evaluate the safety and efficacy of a Healing Ointment in skin improvement after dermatologic procedures such as Mohs surgery, skin biopsy, excision on the head/neck or body.

The study is designed to enroll approximately 20 subjects, in which 10 subjects undergo dermatologic procedure on the head/neck and 10 subjects on the body.

Eligible subjects apply the test product twice daily after the procedure, followed by efficacy and tolerability assessments, standard photography, and self-assessment questionnaire at each follow-up visit.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subject who undergo Mohs surgery, skin biopsy, excision on the head/neck or body
  • Ability of giving consent for participation in the study
  • Agreement to adhere to the procedures and requirements of the study and to report to the institute on the day(s) and at the time(s) scheduled for the assessments

排除标准

  • History of allergy or hypersensitivity to cosmetic ingredients
  • Pregnant, planning pregnancy during the course of the study or breastfeeding
  • Subject with a history of keloids or hypertrophic scars
  • Presence of tattoo and/or scar in the treatment area that in the investigator's opinion would interfere with study assessments
  • Subjects with history of or the presence of any skin condition/disease that might interfere with the diagnosis or evaluation of study parameters (i.e., atopic dermatitis, eczema, psoriasis, seborrheic dermatitis) at the discretion of the investigator
  • Subjects with inability to comply with all study protocol restrictions and visits

研究组 & 干预措施

Healing Ointment

Experimental

Petrolatum-based opaque ointment applied to surgical wound twice daily.

干预措施: Cetaphil Healing Ointment (Drug)

结局指标

主要结局

Objective Erythema Assessment Using Clinical Grading Analog Scale

时间窗: Immediately post-procedure (on the same day of the procedure), day 7/14, and day 28 from baseline

Summary of change in tolerability from baseline to day 28, at the surgical area after using the Healing Ointment daily. Lower scores reflect a better outcome. Erythema assessment was graded clinically based on a scale from 0 to 3 (0 = none, 1 = mild, 2 = moderate, 3 = severe).

Objective Edema Assessment Using Clinical Grading Analog Scale

时间窗: Immediately post-procedure (on the same day of the procedure), day 7/14, and day 28 from baseline

Summary of change in tolerability from baseline to day 28, at the surgical area after using the Healing Ointment daily. Lower scores reflect a better outcome. Edema assessment was graded clinically based on a scale from 0 to 3 (0 = none, 1 = mild, 2 = moderate, 3 = severe).

Objective Overall Wound Appearance Assessment Using Clinical Grading Analog Scale

时间窗: Immediately post-procedure (on the same day of the procedure), day 7/14, and day 28 from baseline

Summary of change in tolerability from baseline to day 28, at the surgical area after using the Healing Ointment daily. Lower scores reflect a better outcome. Overall wound appearance was graded clinically based on a scale from 0 to 3 (0 = excellent, 1 = good, 2 = fair, 3 = poor).

Objective Scabbing/Crusting Assessment Using Clinical Grading Analog Scale

时间窗: Immediately post-procedure (on the same day of the procedure), day 7/14, and day 28 from baseline

Summary of change in tolerability from baseline to day 28, at the surgical area after using the Healing Ointment daily. Lower scores reflect a better outcome. Scabbing/crusting assessment was graded based on a scale from 0 to 4 (0 = none, 1 = slight, 2 = moderate, 3 = extensive, 4 = almost complete/complete).

Subjective Burning Assessment Using an Analog Scale

时间窗: Immediately post-procedure (on the same day of the procedure), day 7/14, and day 28 from baseline

Summary of change in tolerability from baseline to day 28, at the surgical area after using the Healing Ointment daily. Lower scores reflect a better outcome. Burning assessment was graded by subjects based on a scale from 0 to 3 (0 = none, 1 = mild, 2 = moderate, 3 = severe).

Subjective Itching Assessment Using an Analog Scale

时间窗: Immediately post-procedure (on the same day of the procedure), day 7/14, and day 28 from baseline

Summary of change in tolerability from baseline to day 28, at the surgical area after using the Healing Ointment daily. Lower scores reflect a better outcome. Itching assessment was graded by subjects based on a scale from 0 to 3 (0 = none, 1 = mild, 2 = moderate, 3 = severe).

Subjective Pain Assessment Using an Analog Scale

时间窗: Immediately post-procedure (on the same day of the procedure), day 7/14, and day 28 from baseline

Summary of change in tolerability from baseline to day 28, at the surgical area after using the Healing Ointment daily. Lower scores reflect a better outcome. Pain assessment was graded by subjects based on a scale from 0 to 3 (0 = none, 1 = mild, 2 = moderate, 3 = severe).

次要结局

  • Subject Satisfaction Using a Self-assessment Questionnaire(Day 28)

研究者

发起方
Galderma R&D
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验